PHAS Stock Price, News & Analysis
Company Description
PHAS (NASDAQ: PHAS) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
PHAS stock has declined 98.3% over the past year.
This page provides a comprehensive overview of PHAS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
PHAS (PHAS) stock. Over the past 12 months, the stock has lost 98.3%.
Latest News
PHAS has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 7 with negative movement. Key topics include earnings, fda approval, conferences, clinical trial. View all PHAS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PHAS Company Profile & Sector Positioning
PHAS (PHAS) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.